Systems and methods for detection of VT and VF from remote sensing electrodes

• US 7,403,813 B1
• Filed: 11/24/2004
• Issued: 07/22/2008
• Est. Priority Date: 11/24/2004
• Status: Active Grant

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Inventors: Noren, Kjell, Bornzin, Gene A., Farazi, Taraneh Ghaffari, Nabutovsky, Yelena, Bjorling, Anders
• Primary Examiner(s): Bockelman; Mark W
• Assistant Examiner(s): Bertram; Eric D
• Application Number:
  US10/998,026
• Time in Patent Office: 1,336 Days
• Field of Search: 600/515
• US Class Current: 600/515
• CPC Class Codes: A61B 5/364 Detecting abnormal ECG interval, e.g. extrasystoles, ectopic heartbeats
• CPC Class Codes: A61N 1/3621 for treating or preventing abnormally high heart rate
• CPC Class Codes: A61N 1/36535 controlled by body position or posture
• CPC Class Codes: A61N 1/36542 controlled by body motion, e.g. acceleration
• CPC Class Codes: A61N 1/36564 controlled by blood pressure

Abstract

Methods and systems are provided for performing ventricular arrhythmia monitoring using at least two sensing channels that are each associated with different sensing vectors, for example by different pairs of extracardiac remote sensing electrodes. Myopotential associated with each of the sensing channels in monitored, and a ventricular arrhythmia monitoring mode is selected based thereon (e.g., based on determined myopotential levels). Ventricular arrhythmia monitoring is then performed using the selected monitoring mode. This description is not intended to be a complete description of, or limit the scope of, the invention. Other features, aspects, and objects of the invention can be obtained from a review of the specification, the figures, and the claims.

Claims

1. In an implantable system, a method for performing ventricular arrhythmia monitoring comprising:

(a) monitoring skeletal muscle myopotential associated with at least two sensing channels, each of which is associated with a different sensing vector, each sensing vector defined by a different pair of spaced apart electrodes, and determining a myopotential level for each of the sensing channels, wherein the myopotential level may be one of a low, medium and high myopotential level;

(b) selecting one of a dual-channel or a single-channel ventricular arrhythmia monitoring mode based on the determined myopotential levels; and

(c) performing ventricular arrhythmia monitoring using the selected monitoring mode.

2. In an implantable system, a method for performing ventricular arrhythmia monitoring comprising:

(a) monitoring myopotential associated with each of at least two sensing channels, each of which is associated with a different sensing vector, each sensing vector defined by a different pair of spaced apart electrodes, and determining a myopotential level for each of the sensing channels;

(b) selecting a ventricular arrhythmia monitoring mode based on the determined myopotential levels; and

(c) performing ventricular arrhythmia monitoring using the selected monitoring mode;

wherein step (b) comprises;

if at least one of the sensing channels is determined to have a low myopotential level, then selecting a single channel ventricular arrhythmia monitoring mode in which a single channel having a low myopotential level is selected for monitoring; and

if none of the sensing channels are determined to have a low myopotential level, then selecting a dual channel ventricular arrhythmia monitoring mode in which two of the sensing channels are selected for monitoring.

3. The method of claim 2, wherein, if a single channel ventricular arrhythmia monitoring mode is selected at step (b), then step (c) comprises:

performing thresholding to detect R-waves and a heart rate in the single channel that is selected for monitoring;

making an initial diagnosis using results of the thresholding.

4. In an implantable system, a method for performing ventricular arrhythmia monitoring comprising:

(a) monitoring myopotential associated with each of at least two sensing channels, each of which is associated with a different sensing vector, each sensing vector defined by a different pair of spaced apart electrodes, and determining a myopotential level for each of the sensing channels;

(b) selecting a ventricular arrhythmia monitoring mode based on the determined myopotential levels;

(c) performing ventricular arrhythmia monitoring using the selected monitoring mode;

wherein, if a dual channel ventricular arrhythmia monitoring mode is selected at step (b), and two of the sensing channels are determined to have a medium myopotential level, then step (c) comprises;

performing simultaneous match filtering in each of the two sensing channels having a medium myopotential level, by running a match filter using a previously stored sinus template associated with the channel, such that an R-wave is detected when the match filters for the two sensing channels both indicate a match to their own previously stored sinus template; and

making an initial diagnosis using results of the simultaneous match filtering.

5. The method of claim 4, further comprising:

(d) if a ventricular arrhythmia treatable by a shock is diagnosed at step (c), then using a non-cardiac parameter sensor to check for a false initial diagnosis before delivering the shock.

6. An implantable system for performing ventricular arrhythmia monitoring using at least two sensing channels that are each associated with different sensing vectors, comprising:

a myopotential detector to monitor skeletal muscle myopotential associated with each of the sensing channels; and

an arrhythmia monitor to select one of a dual-channel or a single-channel ventricular arrhythmia monitoring mode based on the monitored myopotential, and to perform ventricular arrhythmia monitoring using the selected monitoring mode;

wherein the myopotential detector assigns each sensing channel one of a low, medium and high myopotential level.

7. The system of claim 6, wherein the different sensing vectors are defined by extracardiac remote sensing electrodes that are subcutaneously implanted in a patient.

8. An implantable system for performing ventricular arrhythmia monitoring using at least two sensing channels that are each associated with different sensing vectors, comprising:

a myopotential detector to monitor myopotential associated with each of the sensing channels; and

an arrhythmia monitor to select a ventricular arrhythmia monitoring mode based on the monitored myopotential, and to perform ventricular arrhythmia monitoring using the selected monitoring mode;

wherein the monitor;

selects a single channel ventricular arrhythmia monitoring mode in which a single channel having a low myopotential level is selected for monitoring, if at least one of the sensing channels is determined to have a low myopotential level; and

selects a dual channel ventricular arrhythmia monitoring mode in which two of the sensing channels are selected for monitoring, if none of the sensing channels are determined to have a low myopotential level.

9. The system of claim 8, wherein, if the monitor selects a single channel ventricular arrhythmia monitoring mode, then the monitor performs thresholding to detect R-waves and a heart rate in the single channel that is selected for monitoring, and the monitor makes an initial diagnosis using results of the thresholding.